Univariate analysis for candidate prognostic factors using Cox proportional hazards model
Candidate factor . | PFS . | OS . | ||
---|---|---|---|---|
Hazard ratio (95% CI) . | P . | Hazard ratio (95% CI) . | P . | |
GHSG risk score | .036 | |||
Low | Reference group | Reference group | ||
Intermediate | 6.72 (0.87-52.01) | .068 | No events | |
High | 6.02 (0.72-50.45) | .098 | No events | |
ECOG performance status (1 vs 0) | 0.97 (0.90-2.40) | .94 | 1.19 (0.33-4.23) | .79 |
Stage III/IV vs I/II | 1.22 (0.50-3.00) | .66 | 1.17 (0.33-4.41) | .81 |
Male sex | 5.08 (1.17-22.00) | .008 | >100* | .006 |
B symptoms | 1.76 (0.63-4.94) | .28 | 1.20 (0.25-5.70) | .82 |
Splenic involvement | 6.94 (2.07-23.26) | .002 | 1.57 (0.33-7.50) | .57 |
Bone marrow involvement | 1.60 (0.46-5.61) | .46 | 0.77 (0.10-6.20) | .81 |
Transformed histology at diagnosis | 0.49 (0.06-3.80) | .50 | <0.01* | .21 |
Albumin < 4.0 g/dL | 1.41 (0.46-4.31) | .54 | 0.92 (0.19-4.42) | .92 |
Histologic variant (non-A/B†) | 1.04 (0.39-2.77) | .94 | 10.4 (0.27-4.04) | .95 |
Candidate factor . | PFS . | OS . | ||
---|---|---|---|---|
Hazard ratio (95% CI) . | P . | Hazard ratio (95% CI) . | P . | |
GHSG risk score | .036 | |||
Low | Reference group | Reference group | ||
Intermediate | 6.72 (0.87-52.01) | .068 | No events | |
High | 6.02 (0.72-50.45) | .098 | No events | |
ECOG performance status (1 vs 0) | 0.97 (0.90-2.40) | .94 | 1.19 (0.33-4.23) | .79 |
Stage III/IV vs I/II | 1.22 (0.50-3.00) | .66 | 1.17 (0.33-4.41) | .81 |
Male sex | 5.08 (1.17-22.00) | .008 | >100* | .006 |
B symptoms | 1.76 (0.63-4.94) | .28 | 1.20 (0.25-5.70) | .82 |
Splenic involvement | 6.94 (2.07-23.26) | .002 | 1.57 (0.33-7.50) | .57 |
Bone marrow involvement | 1.60 (0.46-5.61) | .46 | 0.77 (0.10-6.20) | .81 |
Transformed histology at diagnosis | 0.49 (0.06-3.80) | .50 | <0.01* | .21 |
Albumin < 4.0 g/dL | 1.41 (0.46-4.31) | .54 | 0.92 (0.19-4.42) | .92 |
Histologic variant (non-A/B†) | 1.04 (0.39-2.77) | .94 | 10.4 (0.27-4.04) | .95 |